Merck & Co., Inc: Psoriasis trials
The registry lists 18 Psoriasis studies with Merck & Co., Inc as lead sponsor. 1 are open to participants now and 17 have results posted.
Phase 1 4Phase 2 3Phase 3 6Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)RecruitingNCT07850310Phase 1
- A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)CompletedNCT01276847Phase 1Results posted
- A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)CompletedNCT01235728Phase 1Results posted
- A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)CompletedNCT01225731Phase 2Results posted
- Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)CompletedNCT01140061Phase 1Results posted
- Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)TerminatedNCT00833053Phase 3Results posted
- Assessment of Long-Term Infliximab for Psoriasis (P05319)CompletedNCT00779675Results posted
- Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)CompletedNCT00749398Results posted
- Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)CompletedNCT00727298Results posted
- Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)CompletedNCT00725452Results posted
- A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)CompletedNCT00687401Phase 3Results posted
- A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)CompletedNCT00687362Phase 2Results posted
- Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)CompletedNCT00686686Phase 3Results posted
- A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)CompletedNCT00686595Phase 4Results posted
- A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)CompletedNCT00684593Phase 2Results posted
- Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)TerminatedNCT00358670Phase 3Results posted
- Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)CompletedNCT00254982Phase 3Results posted
- The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)CompletedNCT00251641Phase 3Results posted